Pressmeddelanden

US FDA accepts regulatory submission for acalabrutinib and grants priority review

US FDA accepts regulatory submission for acalabrutinib and grants priority review

2017-08-02 08:04 CEST
AstraZeneca and its haematology research and development centre of excellence, Acerta P...

Acalabrutinib granted breakthrough therapy designation by US FDA for the treatment of patients with mantle cell lymphoma

Acalabrutinib granted breakthrough therapy designation by US FDA for the treatment of patients with mantle cell lymphoma

2017-08-01 08:07 CEST
AstraZeneca and its haematology research and development centre of excellence, Acerta P...

Imfinzi granted breakthrough therapy designation by US FDA for patients with locally-advanced unresectable non-small cell lung cancer

Imfinzi granted breakthrough therapy designation by US FDA for patients with locally-advanced unresectable non-small cell lung cancer

2017-07-31 08:04 CEST
Fourth Breakthrough Therapy Designation for an AstraZeneca New Oncology medicine in thr...

Tagrisso significantly improves progression-free survival in the phase III FLAURA trial for lung cancer

Tagrisso significantly improves progression-free survival in the phase III FLAURA trial for lung cancer

2017-07-27 09:19 CEST
AstraZeneca today announced that the Phase III FLAURA trial showed a statistically-sign...

AstraZeneca reports initial results from the ongoing MYSTIC trial in stage IV lung cancer

2017-07-27 09:13 CEST
AstraZeneca and MedImmune today announced progression-free survival (PFS) results for t...

AstraZeneca and Merck establish strategic oncology collaboration

AstraZeneca and Merck establish strategic oncology collaboration

2017-07-27 09:09 CEST
AstraZeneca and Merck & Co., Inc., today announced that they have entered a global str...

Faslodex receives EU approval as first-line therapy for advanced breast cancer

Faslodex receives EU approval as first-line therapy for advanced breast cancer

2017-07-26 17:53 CEST
AstraZeneca today announced that the European Commission (EC) has approved Faslodex (fu...

Upptäckter som räddar liv – årets tema för Sommarforskarskolan

Upptäckter som räddar liv – årets tema för Sommarforskarskolan

2017-07-24 10:42 CEST
Måndag 31 juli öppnas portarna till årets upplaga av AstraZenecas sommarforskarskola oc...

Ny typ av immunterapi mot lungcancer och cancer i urinblåsan har tagit ett viktigt steg mot godkännande inom EU

2017-07-24 07:00 CEST
Immunterapiläkemedlet atezolizumab har fått ett positivt utlåtande av EU:s medicinska k...